Orios Venture Partners has refunded ₹300 crore to investors from Fund I, foreseeing increased returns this year. Launched in 2014 with a final close at ₹300 crore in 2015, Fund I focused on health tech, consumer-tech, and ecommerce, investing in 18 companies.
Rehan Yar Khan, Managing Partner, highlighted, “We are glad to have returned 1x of the fund, which means the corpus invested with us is back with investors and now the upside remains.”
Despite challenges due to Covid, the return journey took longer than planned. Khan expressed optimism, saying, “Hopefully, such black swan events will not repeat in our lifetime.”
Fund I concentrated on Marketplaces (27.07%), D2C (17.7%), and HealthTech (14.45%). Key portfolio companies include Country Delight, Pharmeasy, Intelligence Node, and Zostel.
Khan reflected on the evolving tech landscape, “Tech has reached across India and into the hinterland, beyond consumer internet to B2B, SaaS, EVs, Climatetech, and hardware.”
Orios Venture Partners, now investing from its fourth fund, sees the Indian tech opportunity growing. Khan stated, “Looking back to Fund I, we can see that the opportunity for startups has grown manyfold.”
The company emphasized the significance of capital returning, stating, “This is the beginning of an extended positive cycle.”
